Project Grant R01NS141156

Award Date 6/3/25
Completion Date 5/31/30
Dollars Obligated $462K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Kentucky, USA
Similar Awards
This federal Project Grant award of $591,304 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to investigate the role of the integrated stress response (ISR) kinase HRI in the secondary injury and neuroinflammation that occurs after traumatic spinal cord injury (SCI). The research aims to evaluate the cell-autonomous effects of HRI on...
This $424,875.00 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will fund a comprehensive study of gene transcription patterns in diverse classes of neurons that connect the brain to the spinal cord after spinal cord injury in a mouse model. The research team at Marquette University will use single-cell sequencing technologies to profile...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $291,284 to Drexel University to conduct research on the role of medial deep dorsal glycinergic interneurons in improving locomotion following spinal cord injury (SCI). The key objectives of the research are to: 1) Identify the population of medial laminae V/VI...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program will provide $506,696.00 to the University of Washington to examine the impact of aging and sex on microvascular blood flow and tissue perfusion in the injured spinal cord. The research aims to gain insights into how trauma-induced changes in microvascular density can increase...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $411,941 to Drexel University to conduct research on identifying novel trunk reflex pathways and how they differ after neonatal versus adult spinal cord injury in animal models. The key objectives are to test the hypothesis that the newly discovered contralateral monosynaptic trunk...
This $391,250 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program aims to develop effective therapeutic strategies for spinal cord injury (SCI) by evaluating controlled PTEN deletion and chondroitin sulfate proteoglycans (CSPGs) degradation to promote axon regeneration and functional recovery. The key objectives are to: 1) Temporally evaluate...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $1,006,322 in funding to the University of California, San Diego (UCSD) to conduct research on understanding the molecular mechanisms regulating axon regeneration after spinal cord injury. The key products and services to be delivered under this 5-year grant include: 1)...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $469,898 in funding to Yale University from April 1, 2025 to March 31, 2027. The award supports research to define the capacity and necessity of intact and lesioned supraspinal raphespinal tract (RPST) terminals in supporting rehabilitation-induced functional recovery...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $566,089 to The Ohio State University to conduct research on the impacts of pneumonia on spinal cord injury recovery. The research aims to identify the mechanisms by which acute pneumonia exacerbates spinal cord injury, with a focus on understanding the role of circulatory...
This $341,958 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research to define the role of macrophage migration inhibitory factor (MIF) in driving neuropathic pain after spinal cord injury (SCI). The research aims to determine how MIF and its downstream signaling contribute to a hyperactive state in nociceptor sensory neurons, and whether...

This federal Project Grant award, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to investigate the anatomical plasticity and functional impact of specific spinal cord interneurons, known as long-ascending propriospinal neurons (LAPNs), in the context of spinal cord injury.

The $462,296 award, with a project period from June 2025 to May 2030, will enable the University of Louisville to study LAPN dendritic and axonal anatomy before and after various spinal cord injuries in adult rats. The research will also examine the interactions between reticulospinal axons and LAPNs, and the impact of silencing LAPNs on functional recovery following different types of spinal cord injuries. Advanced imaging techniques and machine learning-aided locomotor analysis will be utilized. The findings are expected to provide insights into the adaptive and maladaptive roles of LAPN plasticity, with potential translational applications for cell, drug, and neuromodulation therapies to improve outcomes for individuals with spinal cord injuries.

Generated 7/1/25, 2:18 AM